To date, DCLK1 has been demonstrated to be a relatively selective marker of several kinds of cancer stem-like cells or cancer stem cells (CSCs) including in colon, breast, pancreas, kidney, and esophageal cancers [14,15,16,17]. The gene discussed is DCLK1; the disease is esophageal cancer.